• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
Back

Corporate News

Norris Medicines’ board approved the Directors Report and scheduled the Annual General Meeting
03-Sep-2026, 07:06

Norris Medicines Limited informed the BSE that its board of directors approved the company’s Directors Report for the financial year ended March 31, 2026, and convened the 35th Annual General Meeting on September 29, 2026, via video conferencing or other audio-visual means, with Mr. Hemant Shetye, or Mr. Kunal Sakpal, appointed as scrutinizer and Purva Sharegistry (India) Pvt. Ltd. authorized to facilitate the e-voting process.